Hahn Jong Woo, Yang Hye Ran, Moon Jin Soo, Chang Ju Young, Lee Kwanjoo, Kim Gi Ae, Rahmati Masoud, Koyanagi Ai, Smith Lee, Kim Min Seo, López Sánchez Guillermo F, Elena Dragioti, Shin Ju-Young, Shin Jae Il, Kwon Rosie, Kim Soeun, Kim Hyeon Jin, Lee Hojae, Ko Jae Sung, Yon Dong Keon
Department of Paediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Department of Paediatrics, Seoul National University Bundang Hospital, Seongnam, South Korea.
EClinicalMedicine. 2023 Oct 17;65:102280. doi: 10.1016/j.eclinm.2023.102280. eCollection 2023 Nov.
Autoimmune hepatitis (AIH) varies significantly in incidence and prevalence across countries and regions. We aimed to examine global, regional, and national trends in incidence and prevalence of AIH from 1970 to 2022.
We conducted a thorough search of the PubMed/MEDLINE, Embase, CINAHL, Google Scholar, and Cochrane databases from database inception to August 9, 2023, using the search term "autoimmune hepatitis" in combination with "incidence," "prevalence," or "trend." Only general population-based observational studies with larger samples sizes were considered for inclusion. Studies that recruited convenience samples, and those with fewer than 50 participants were excluded. Summary data were extracted from published reports. A random effects model was used and pooled estimates with 95% CI were used to calculate the incidence and prevalence of AIH. Heterogeneity was evaluated using the statistic. The study protocol was registered with PROSPERO, CRD42023430138.
A total of 37 eligible studies, encompassing more than 239 million participants and 55,839 patients with AIH from 18 countries across five continents, were included in the analysis. Global pooled incidence and prevalence of AIH were found to be 1.28 cases per 100,000 inhabitant-years (95% CI, 1.01-1.63, = 99·51%; number of studies, 33; sample population, 220,673,674) and 15.65 cases per 100,000 inhabitants (95% CI, 13.42-18.24, = 99·75%; number of studies, 26; sample population, 217,178,684), respectively. The incidence of AIH was greater in countries with high Human Development Index (>0.92), in North America and Oceania (compared with Asia), among females, adults (compared with children), and high latitude (>45°). Similar patterns in AIH prevalence were observed. Pooled AIH prevalence increased gradually from 1970 to 2019 (1970-1999; 9.95 [4.77-15.13], = 95·58% versus 2015-2022; 27.91 [24.86-30.96], = 99·32%; cases per 100,000 inhabitants). The overall incidence and prevalence of AIH, as well as some subgroup analyses of the studies, displayed asymmetry in the funnel plots, suggesting potential evidence of publication bias.
AIH incidence and prevalence have increased significantly and exhibit substantial variation across regions worldwide. Further research is required to assess the incidence and prevalence of AIH, specifically in South America and Africa.
National Research Foundation of Korea.
自身免疫性肝炎(AIH)在不同国家和地区的发病率和患病率差异显著。我们旨在研究1970年至2022年期间AIH发病率和患病率的全球、区域和国家趋势。
我们对PubMed/MEDLINE、Embase、CINAHL、谷歌学术和Cochrane数据库进行了全面检索,检索时间从数据库建立至2023年8月9日,检索词为“自身免疫性肝炎”并结合“发病率”“患病率”或“趋势”。仅纳入基于普通人群且样本量较大的观察性研究。排除招募便利样本的研究以及参与者少于50人的研究。从已发表报告中提取汇总数据。使用随机效应模型并采用95%置信区间的合并估计值来计算AIH的发病率和患病率。使用统计量评估异质性。该研究方案已在PROSPERO注册,注册号为CRD42023430138。
分析共纳入37项符合条件的研究,涉及来自五大洲18个国家的超过2.39亿参与者和55839例AIH患者。全球AIH的合并发病率和患病率分别为每10万居民年1.28例(95%置信区间,1.01 - 1.63,I² = 99.51%;研究数量,33;样本人群,220673674)和每10万居民15.65例(95%置信区间,13.42 - 18.24,I² = 99.75%;研究数量,26;样本人群,217178684)。在人类发展指数较高(>0.92)的国家、北美洲和大洋洲(与亚洲相比)、女性、成年人(与儿童相比)以及高纬度地区(>45°),AIH的发病率更高。AIH患病率也观察到类似模式。从1970年到2019年,合并的AIH患病率逐渐上升(1970 - 1999年;9.95 [4.77 - 15.13],I² = 95.58%,与2015 - 2022年;27.91 [24.86 - 30.96],I² = 99.32%;每10万居民中的病例数)。AIH的总体发病率和患病率以及研究的一些亚组分析在漏斗图中显示不对称,表明存在发表偏倚的潜在证据。
AIH的发病率和患病率显著增加,且在全球各地区存在很大差异。需要进一步研究以评估AIH的发病率和患病率,特别是在南美洲和非洲。
韩国国家研究基金会。